SLC2A3 and cancer: In line with reported effects of arginine on glycolysis in cancers,19,20,21 we observed increased expression of glucose transporter 3 (GLUT3) and hexokinase 2 (HK2) in ARG1/AGMAT-expressing cells (Figures 3F and 3G).